A hybrid optical device that uses a multimode fiber coupled to a tunable light source for illumination and a 2.4-mm photodiode for detection in contact with the tissue surface is developed as a first step toward our goal of developing a cost-effective, miniature spectral imaging device to map tissue optical properties in vivo. This device coupled with an inverse Monte Carlo model of reflectance is demonstrated to accurately quantify tissue absorption and scattering in tissue-like turbid synthetic phantoms with a wide range of optical properties. The overall errors for quantifying the absorption and scattering coefficients are 6.0± 5.6 and 6.1± 4.7%, respectively. Compared with fiber-based detection, having the detector right at the tissue surface can significantly improve light collection efficiency, thus reducing the requirement for sophisticated detectors with high sensitivity, and this design can be easily expanded into a quantitative spectral imaging system for mapping tissue optical properties in vivo.
UV-visible diffuse reflectance spectroscopy ͑UV-VIS DRS͒ is sensitive to the absorption and scattering properties of biological molecules in tissue and thus can be used as a tool for quantitative tissue physiology in vivo. One major absorber of light in mucosal tissue in the visible range is hemoglobin ͑Hb͒, which shows distinctive, wavelength-dependent absorbance characteristics depending on its concentration and oxygenation. Tissue scattering is sensitive to the size and density of cellular structures such as nuclei and mitochondria. Thus, DRS of tissues can quantify changes in oxygenation, blood volume and alterations in cellular density and morphology. Some potential clinical applications of UV-VIS DRS include monitoring of tissue oxygenation, 1 precancer and cancer detection, 2,3 intraoperative tumor margin assessment, 4 and assessing tumor response to cancer therapy. 1 Our group has developed a fiber optic DRS system 5 and a fast inverse Monte Carlo ͑MC͒ model of reflectance 6 to nondestructively and rapidly quantify tissue absorption and scattering properties. The system consists of a 450-W xenon lamp, a monochromator, a fiber optic probe, an imaging spectrograph, and a CCD camera. Previously published studies by our group 7 show that this technology is capable of quantifying breast tissue physiological and morphological properties, and that these quantities can be used to discern between malignant and non-malignant tissues with sensitivities and specificities exceeding 80%. Although this technology coupled with the MC model is a robust toolbox for quantifying tissue optical properties, this system suffers from several drawbacks similar to other spectrometers. First, optical fibers when used for detection, collect a relatively small portion of the remitted signal, thus high-quantum-efficiency, low-noise detectors are required to detect the signal, particularly in the UV-blue spectral region. Optical-fiber-based detection, while reasonable for single-point sampling, is unwieldy and expensive when expanded for use in imaging applications. Thus, a simpler, lowcost, and more portable reflectance spectrometer, capable of making fast measurements and easily extendable into a spectral imaging platform for mapping tissue optical properties is desirable for clinical applications. Previous studies have attempted to develop a portable DRS probe for cancer detection. Cerussi et al. 8 developed a handheld ͑5 ϫ 8 ϫ 10 cm͒ laser breast scanner ͑LBS͒ based on frequency-domain nearinfrared spectroscopy for breast cancer detection. The LBS probe consists of a fiber bundle for illumination and an avalanche photodiode module placed 22 mm from the fiber bundle for detection. Feather et al. 9 reported a portable diffuse reflectometer that uses nine LEDs at three visible wavelengths to illuminate skin and a photodiode to collect diffusely reflected light, through a 7-mm aperture. The LBS has a sensing depth over 1 cm, but is difficult to multiplex into a spectral imaging device because of the size of the device. The LEDphotodiode-based reflectometer is extendable to imaging, but measurements based on this device does not provide quantitative endpoints such as absorption and scattering, which relate to the underlying biology of the tissue.
Our long-term goal is to develop a cost-effective, miniature spectral imaging device for quantifying tumor physiology and morphology with performance comparable to its benchtop counterpart. In this letter, we describe a single-point hybrid optical probe that consists of a multimode illumination fiber and a silicon photodiode as a first step toward the long-term goal. We demonstrate that diffuse reflectance ͑DR͒ spectra measured with the hybrid system coupled with our inverse MC model provides quantitative measures of tissue absorption and scattering with accuracy that is comparable to that of the original benchtop system.
The hybrid system, shown in Fig. 1͑a͒ , consists of a 450-W xenon lamp and monochromator ͑JY Horiba, Edison, New Jersey͒, a 1-mm illumination optical fiber ͓numerical aperture ͑NA͒ = 0.22͔, a 2.4-mm silicon photodiode ͑S1226, Hamamatsu, Japan͒ with a low-noise current amplifier ͑PDA-750, Terahertz Technologies Inc., Oriskany, New York͒, and a laptop computer. The hybrid system uses the same light source and monochromator and an illumination fiber with similar diameter and NA as the original system. The primary difference between the two systems is that the photodiode and current amplifier in the new system replace the collection fibers, spectrograph, and CCD camera in the original system. At the distal end of the probe ͓Fig. 1͑b͔͒ the edge of the photodiode was trimmed to the active area and transparent epoxy was used to bond the cleaved fiber adjacent to the photodiode, such that the center-to-center distance between the fiber and the photodiode is 2.1 mm. The overall diameter of the probe tip is 6 mm. The maximum power out of the illumination fiber was 130 W at 470 nm, and the minimum power was 65 W at 590 nm. This system has significantly lower cost and better collection efficiency than the original system because of the larger NA of the silicon photodiode ͑NA= 0.96͒ and its direct contact with the sample. It can also be easily multiplexed into a spectral imaging device by interfacing a bundle of optical fibers to the exit slit of the monochromator and separating the fibers at the distal end, such that each fiber is coupled to a discrete photodiode within a large matrix of photodiodes.
To evaluate the performance of the modified system, a series of experiments were conducted on homogeneous tissue phantoms. Prior to the phantom experiments, the long-term drift and signal-to-noise ratio ͑SNR͒ of the system were characterized. We determined that the drift of the system was less than 1 nA over 2 h with the lamp on and the probe tip in contact with the surface of a liquid phantom. By taking three consecutive DR spectra from 400 to600 nm in the darkest phantom among the 10 phantoms described in the following, we calculated an average SNR ͓=20 log͑mean intensity/ standard deviation͔͒ of 42.9 dB over all wavelengths and a minimum SNR of 24.6 dB at 410 nm, which is close to the Soret band of oxy-Hb.
Phantoms with absorption coefficient ͑ a ͒ and reduced scattering coefficient ͑ s Ј͒ representative of human breast tissues in the 400 to 600-nm wavelength range 6 were created with the scatterer, 1-m-diam polystyrene spheres ͑07310-15, Polysciences, Inc., Warrington, Pennsylvania͒ and variable concentrations of the absorber, Hb ͑H0267, Sigma Co., St. Louis, Missouri͒. Two sets of liquid phantoms were created by titrating the absorber at two scattering levels, and all DR measurements were made the day the phantoms were prepared. The first set of phantoms ͑1A to 1E͒ consisted of five low-scattering phantoms ͑wavelength-averaged s Ј Ϸ 10.6 cm −1 ͒ with wavelength-averaged a of 0.49, 0.88, 1.28, 1.58, and 1.97 cm −1 over the 400 to 600-nm range. The second set ͑2A to 2E͒ consisted of five high-scattering phantoms ͑wavelength-averaged s ЈϷ18.5 cm −1 ͒ with the same a values as the first set. A complete DR spectrum was collected from each phantom by scanning the bandpass of the monochromator ͑4.5 nm͒ from 400 to 600 nm at increments of 5 nm. Then, a DR spectrum was also obtained from a Spectralon 99% diffuse reflectance puck ͑SRS-99-010, Labsphere, Inc., North Sutton, New Hampshire͒ with the probe in contact with the puck immediately after the phantom measurements with the same instrument settings.
An inverse MC model 6 was used to extract the a and s Ј of the liquid phantoms. The model was validated in both phantom 6, 10 and clinical studies. 7 The MC forward model assumes a set of absorbers ͑oxy-Hb with known extinction coefficients measured using a spectrophotometer in this case͒ are present in the medium. The scatterer ͑polystyrene microsphere in this study͒ is assumed to be single-sized, spherically shaped, and uniformly distributed. The a ͑͒ of the medium are calculated from the concentration of each absorber and the corresponding extinction coefficients using Beer's law. The s Ј͑͒ and anisotropy factor are calculated using Mie theory. 11 The a ͑͒ and s Ј͑͒ are then input into a scalable MC model of light transport to obtain a modeled DRs spectrum. In the inverse model, the modeled DR is adaptively fitted to the measured tissue DR. When the sum of square error between the modeled and measured DR is minimized, the concentrations of absorber, from which a can be derived, and s Ј are extracted. To experimentally compare measured phantom spectra to MC simulated phantom spectra for the fitting process, the "calibrated" DR spectrum of the target phantom for which the optical properties are to be quantified, was divided point by point by the "calibrated" DR spectrum of a reference phantom with known optical properties. The term "calibrated" in both cases refers to the normalization of the DR spectrum to that measured from the Spectralon puck for correction of the wavelength-dependent response of the instrument. In this phantom study, phantom 1C ͑wavelength-averaged a = 1.28 cm −1 , wavelength-averaged s Ј=10.6 cm −1 ͒ was selected as a reference phantom and the remaining nine phantoms were used as targets. Bender et al. previously provided guidelines for the selection of a reference phantom. 10 Figure 2 shows the Spectralon puck-calibrated reflectance spectra for two phantoms 1A and 1E and the corresponding fits to the MC model. The three valleys at 415, 540, and 575 nm on the spectra for both phantoms are the Soret band ͑400 to 450 nm͒, ␣ band ͑540 nm͒, and ␤ band ͑569 nm͒ of oxygenated Hb, respectively. There is excellent agreement between the measured spectra and the fits. Figures 3͑a͒ and 3͑b͒ show the extracted versus expected a and s Ј for all wavelengths over the 400 to 600-nm range quantified with the modified and original systems for the similar range of optical properties. The 10 phantoms tested with the modified system have an overall a range of 0.035 to 10 cm −1 and a s Ј range of 9.2 to 22.2 cm −1 , while that tested with the original system have overall a and s Ј ranges of 0.008 to 16.0 cm −1 and 9.3 to 23.2 cm −1 , respectively. The reference phantom used for measurements made with the original system had a wavelength-averaged a = 2.0 cm −1 and s Ј=10.6 cm −1 . The correlation coefficients for a and s Ј are 0.9981 and 0.9588, respectively, for optical properties quantified with the modified system. An overall error of 6.0Ϯ 5.6% was calculated for a and 6.1Ϯ 4.7% for s Ј for the modified system. For the purposes of comparison, the original system had a overall errors 5.8Ϯ 5.1 and 3.0Ϯ 3.1% for extracting a and s Ј, respectively.
The modified system can quantify absorption from phantoms with modest absorption coefficients ͑up to 10 cm −1 ͒. Compared to the original system, the modified system has higher errors in extraction of scattering coefficient due to its 10 to 15-dB lower SNR for high scattering. The dynamic range of the system may be improved by decreasing the center-to-center distance between the source and detector as well as by increasing the area of the photodiode.
We believe that the modified system combined with our MC model can be extended into an optical spectral imaging system to map out the concentrations of absorbers and the bulk tissue scattering properties of subsurface tissue volumes, which are on a length scale of several millimeters. There are a number of applications for which this technology would be ideally suited, including epithelial precancer and cancer detection ͑such as those of the skin, oral cavity, and cervix͒, intraoperative tumor margin assessment, and the monitoring of tumor response to therapy in organ sites such as the head and neck and cervix. More importantly, placing the detector directly at the tissue surface will improve collection efficiency and will significantly reduce the cost associated with expensive and sophisticated CCDs.
